Keywords: Academic detailing, Information to doctors, AHRQ

US Congressional leaders back AHRQ funding of "Academic Detailing" programs to improve information to doctors on Rx drugs

Article | 21 April 2010

The US Agency for Healthcare Research and Quality (AHRQ) last week directed $29.5 million in economic stimulus funds to 9,000 programs nationwide that aim to put straightforward, unbiased information about the wide range of available prescription drug treatments - known as “comparative effectiveness research” - into the hands of America’s physicians and their patients.

The move was commended by US Senate Special Committee on Aging Chairman Herb Kohl (Democrat, Wisconsin), Senate Majority Whip Dick Durbin (Democrat, Illinois), House Committee on Energy and Commerce Chairman Henry Waxman (Democrat, California), and House Energy and Commerce Subcommittee on Health Chairman Frank Pallone (Democrat, New Jersey). Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in